Loss of Autonomy in the Elderly: Relationships Between Gut Microbiota Diversity, Nutrition and Cognitive and Sensory-motor Disturbances in "Small Eaters" and "Non Small Eaters"

NCT ID: NCT05449119

Last Updated: 2024-08-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

140 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-06-13

Study Completion Date

2028-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Older adults currently make up 25% of the population in France, and future health expenditures will be largely related to the consequences of aging. Normal aging is associated with a progressive decrease in cognitive and sensorimotor function, malnutrition and/or under-nutrition and intestinal dysbiosis (i.e. changes in the composition and/or stability of the microbiota). Furthermore, admission to long-term care facilities such as Etablissement d'Hébergement pour Personnes Agées Dépendantes (EHPAD) leads to drastic changes in lifestyle in terms of (i) nutrition and (ii) motor functions. These modifications can influence the composition of the intestinal microbiota and its temporal evolution.

We will study the relationship between the deterioration of cognitive and sensorimotor function, diet and intestinal well-being (i.e. microbiota) of a cohort of older adults (\>75 years) defined as "small eaters" from their admission in EHPAD at the University Hospital of Dijon. This study will be carried out by a unique French multidisciplinary consortium that includes academics and health professionals, who will be able to specify the criteria defining the "small eaters" and to envisage suitable dietary strategies aiming to preserve their nutritional status and intestinal well-being. The final goal is to improve quality of life at home by prolonging autonomy and independence, and thus to deferring admission to an EHPAD for as long as possible.

The objective of this study is to build a cohort of elderly "small eaters" and a cohort of elderly "non small eaters". These patients will be followed over a period of one year. The evolution of the composition of the intestinal microbiota will be determined in order to establish the existing relations between the composition of digestive microbiota, the nutritional state, and cognitive and sensorimotor function.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Elderly Small Eater

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Non small eaters

Elderly subjects who are not malnourished

Fecal and blood sampling and collection of nutritional, cognitive and sensorimotor data

Intervention Type BIOLOGICAL

at T0, T3 months, T6 months, T9 months and T12 months

Body Mass Index (BMI)

Intervention Type OTHER

Calculation of BMI with height measurement by heel-knee distance measurement at T0, T3 months, T6 months, T9 months and T12 months

24-hour food and beverage record

Intervention Type OTHER

at T0, T3 months, T6 months, T9 months and T12 months

Mini Nutritional assessment (MNA)

Intervention Type OTHER

at T0, T3 months, T6 months, T9 months and T12 months

Measurement of muscle mass by bioelectrical impedance analysis (except for participants with a pacemaker)

Intervention Type OTHER

at T0, T3 months, T6 months, T9 months and T12 months

Measurement of sensorimotor functions

Intervention Type OTHER

at T0, T3 months, T6 months, T9 months and T12 months

Measurement of cognitive functions

Intervention Type OTHER

at T0, T3 months, T6 months, T9 months and T12 months

Small eaters

Elderly subjects with loss of appetite

Fecal and blood sampling and collection of nutritional, cognitive and sensorimotor data

Intervention Type BIOLOGICAL

at T0, T3 months, T6 months, T9 months and T12 months

Body Mass Index (BMI)

Intervention Type OTHER

Calculation of BMI with height measurement by heel-knee distance measurement at T0, T3 months, T6 months, T9 months and T12 months

24-hour food and beverage record

Intervention Type OTHER

at T0, T3 months, T6 months, T9 months and T12 months

Mini Nutritional assessment (MNA)

Intervention Type OTHER

at T0, T3 months, T6 months, T9 months and T12 months

Measurement of muscle mass by bioelectrical impedance analysis (except for participants with a pacemaker)

Intervention Type OTHER

at T0, T3 months, T6 months, T9 months and T12 months

Measurement of sensorimotor functions

Intervention Type OTHER

at T0, T3 months, T6 months, T9 months and T12 months

Measurement of cognitive functions

Intervention Type OTHER

at T0, T3 months, T6 months, T9 months and T12 months

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Fecal and blood sampling and collection of nutritional, cognitive and sensorimotor data

at T0, T3 months, T6 months, T9 months and T12 months

Intervention Type BIOLOGICAL

Body Mass Index (BMI)

Calculation of BMI with height measurement by heel-knee distance measurement at T0, T3 months, T6 months, T9 months and T12 months

Intervention Type OTHER

24-hour food and beverage record

at T0, T3 months, T6 months, T9 months and T12 months

Intervention Type OTHER

Mini Nutritional assessment (MNA)

at T0, T3 months, T6 months, T9 months and T12 months

Intervention Type OTHER

Measurement of muscle mass by bioelectrical impedance analysis (except for participants with a pacemaker)

at T0, T3 months, T6 months, T9 months and T12 months

Intervention Type OTHER

Measurement of sensorimotor functions

at T0, T3 months, T6 months, T9 months and T12 months

Intervention Type OTHER

Measurement of cognitive functions

at T0, T3 months, T6 months, T9 months and T12 months

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Person who has given oral consent and has not objected to being included in the study, or if necessary, oral consent of an appointed legal representative.
* A person over 75 years of age residing in an EHPAD who may be under guardianship or curatorship.
* A person over 75 years of age with a loss of appetite (i.e. a small eater) residing in an EHPAD, who may be under guardianship or curatorship.

Exclusion Criteria

* Person not affiliated to national health insurance
* Elderly person with an infectious syndrome at the time of admission;
* Elderly person with diarrhoea (infectious or not) at the time of admission;
* Elderly person receiving recently prescribed antimicrobials at the time of admission (antibiotics or antifungals)
* Elderly person with celiac disease and/or Crohn's disease.
* Person under a measure of limited judicial protection
Minimum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre Hospitalier Universitaire Dijon

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Chu Dijon Bourgogne

Dijon, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Frédéric DALLE

Role: CONTACT

0380295014

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Frédéric DALLE

Role: primary

0380295014

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

DALLE CHU 2020

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.